These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20420827)

  • 21. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.
    Balasubramanian S; Babai N; Chaudhuri A; Qiu F; Bhattacharya S; Dave BJ; Parameswaran S; Carson SD; Thoreson WB; Sharp JG; Rao M; Ahmad I
    Stem Cells; 2009 Dec; 27(12):3053-62. PubMed ID: 19859985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and activation of the reprogramming transcription factors.
    Guo J; Li ZC; Feng YH
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reprogramming language of pluripotency.
    Welstead GG; Schorderet P; Boyer LA
    Curr Opin Genet Dev; 2008 Apr; 18(2):123-9. PubMed ID: 18356040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced pluripotent stem cells: will they be safe?
    Jalving M; Schepers H
    Curr Opin Mol Ther; 2009 Aug; 11(4):383-93. PubMed ID: 19649983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From fibroblasts to iPS cells: induced pluripotency by defined factors.
    Zhao R; Daley GQ
    J Cell Biochem; 2008 Nov; 105(4):949-55. PubMed ID: 18668528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors.
    Yakubov E; Rechavi G; Rozenblatt S; Givol D
    Biochem Biophys Res Commun; 2010 Mar; 394(1):189-93. PubMed ID: 20188704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
    Mostoslavsky G
    Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced pluripotent stem cells: opportunities and challenges.
    Okita K; Yamanaka S
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2198-207. PubMed ID: 21727125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming Parkinson's disease research.
    Knight AL; Daigle JG
    Dis Model Mech; 2010; 3(9-10):509-10. PubMed ID: 20647414
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell fate plug and play: direct reprogramming and induced pluripotency.
    Chambers SM; Studer L
    Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducing pluripotency using in vivo gene therapy.
    Gardlik R
    Med Hypotheses; 2012 Aug; 79(2):197-201. PubMed ID: 22595803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.